GoodRx Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by GoodRx Holdings, Inc. on June 10, 2021. The filing details the voting results for director elections and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes are reported in this document. The primary event is the successful election of three Class I directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly documents the outcomes of the shareholder vote.
Key Facts for Investor Verification
- Meeting Date: June 10, 2021.
- Voting Participation: Approximately 98.7% of the combined voting power of Class A and Class B common stock was present or represented by proxy.
- Director Election: Douglas Hirsch, Jacqueline Kosecoff, and Agnes Rey-Giraud were elected as Class I directors for terms expiring in 2024.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified with 3,243,088,795 votes FOR, 264,511 votes AGAINST, and 217,458 votes ABSTAINED.
- Share Structure: Class A shares carry one vote per share, while Class B shares carry ten votes per share.